Hyaline membrane disease: recent developments.
D000551:Ambroxol / Q000627:therapeutic use; D000653:Amniotic Fluid / Q000378:metabolism; D001997:Bronchopulmonary Dysplasia / Q000175:diagnosis; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006819:Hyaline Membrane Disease / Q000175:diagnosis / Q000188:drug therapy*; D007231:Infant, Newborn; D010100:Oxygen / Q000097:blood; D010713:Phosphatidylcholines / Q000378:metabolism; D011175:Positive-Pressure Respiration; D011247:Pregnancy; D011296:Prenatal Diagnosis; D011379:Prognosis; D011663:Pulmonary Surfactants / Q000627:therapeutic use; D013109:Sphingomyelins / Q000378:metabolism
D005938:Glucocorticoids; D010713:Phosphatidylcholines; D011663:Pulmonary Surfactants; D013109:Sphingomyelins; D000551:Ambroxol; D010100:Oxygen